Peng W, Shi M, Hu B, Jia J, Li X, Wang N
Mol Cancer. 2025; 24(1):78.
PMID: 40087758
DOI: 10.1186/s12943-024-02222-5.
Song B
Int J Mol Sci. 2025; 26(5).
PMID: 40076976
PMC: 11900391.
DOI: 10.3390/ijms26052357.
Soranno D, Coopersmith C, Brinkworth J, Factora F, Muntean J, Mythen M
Crit Care. 2025; 29(1):91.
PMID: 40011975
PMC: 11866815.
DOI: 10.1186/s13054-025-05309-7.
Yuan Z
Molecules. 2025; 30(4).
PMID: 40005257
PMC: 11858448.
DOI: 10.3390/molecules30040947.
Yee B, Ali N, Mohd-Naim N, Ahmed M
Chem Bio Eng. 2025; 1(4):330-339.
PMID: 39974464
PMC: 11835143.
DOI: 10.1021/cbe.3c00112.
Molecular insights and rational engineering of a compact CRISPR-Cas effector Cas12h1 with a broad-spectrum PAM.
Zheng W, Li H, Liu M, Wei Y, Liu B, Li Z
Signal Transduct Target Ther. 2025; 10(1):66.
PMID: 39955288
PMC: 11830025.
DOI: 10.1038/s41392-025-02147-5.
Colorimetric aptasensor coupled with a deep-learning-powered smartphone app for programmed death ligand-1 expressing extracellular vesicles.
Khan A, Khan H, He N, Li Z, Alyahya H, Bin Jardan Y
Front Immunol. 2025; 15:1479403.
PMID: 39916963
PMC: 11798968.
DOI: 10.3389/fimmu.2024.1479403.
New frontiers in CRISPR: Addressing antimicrobial resistance with Cas9, Cas12, Cas13, and Cas14.
Ali Agha A, Al-Samydai A, Aburjai T
Heliyon. 2025; 11(2):e42013.
PMID: 39906792
PMC: 11791237.
DOI: 10.1016/j.heliyon.2025.e42013.
CRISPR in clinical diagnostics: bridging the gap between research and practice.
Lafi Z, Ata T, Asha S
Bioanalysis. 2025; 17(4):281-290.
PMID: 39902531
PMC: 11866644.
DOI: 10.1080/17576180.2025.2459520.
NAPTUNE: nucleic acids and protein biomarkers testing via ultra-sensitive nucleases escalation.
Hu T, Ke X, Yu Y, Feng H, Zhang S, Cui Y
Nat Commun. 2025; 16(1):1331.
PMID: 39900931
PMC: 11790866.
DOI: 10.1038/s41467-025-56653-9.
Appraisal of CRISPR Technology as an Innovative Screening to Therapeutic Toolkit for Genetic Disorders.
Shahid A, Zahra A, Aslam S, Shamim A, Ali W, Aslam B
Mol Biotechnol. 2025; .
PMID: 39894889
DOI: 10.1007/s12033-025-01374-z.
CRISPR: fundamental principles and implications for anaesthesia.
Perez A, Mavrothalassitis O, Chen J, Hellman J, Gropper M
Br J Anaesth. 2025; 134(3):839-852.
PMID: 39855935
PMC: 11867086.
DOI: 10.1016/j.bja.2024.11.040.
Evolutionary diversification and succession of soil huge phages in glacier foreland.
Liao H, Li J, Wang Y, Li H, An X, Wang T
Microbiome. 2025; 13(1):18.
PMID: 39838455
PMC: 11748809.
DOI: 10.1186/s40168-024-02017-2.
Novel adaptive immune systems in pristine Antarctic soils.
Van Goethem M, Bezuidt O, Pierneef R, Vikram S, Hopkins D, Aspray T
Sci Rep. 2025; 15(1):2368.
PMID: 39827180
PMC: 11742911.
DOI: 10.1038/s41598-024-83942-y.
Robust genome editing activity and the applications of enhanced miniature CRISPR-Cas12f1.
Park S, Ju S, Jung W, Jeong T, Yoon D, Lee J
Nat Commun. 2025; 16(1):677.
PMID: 39809780
PMC: 11733285.
DOI: 10.1038/s41467-025-56048-w.
CRISPR detection of cardiac tumor-associated microRNAs.
Fu Y, Zhang P, Chen F, Xie Z, Xiao S, Huang Z
Mol Biol Rep. 2025; 52(1):114.
PMID: 39797940
DOI: 10.1007/s11033-024-10205-4.
HRP-integrated CRISPR-Cas12a biosensor for rapid point-of-care detection of Langya henipavirus.
Wu X, Xiang R, Yang D, He X, Zhu L, Sun F
iScience. 2025; 27(12):111466.
PMID: 39758988
PMC: 11697611.
DOI: 10.1016/j.isci.2024.111466.
Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis.
Yazdi Z, Roshannezhad S, Sharif S, Abbaszadegan M
J Transl Med. 2024; 22(1):1173.
PMID: 39741289
PMC: 11686959.
DOI: 10.1186/s12967-024-05908-y.
Mitigating Antibiotic Resistance: The Utilization of CRISPR Technology in Detection.
Zhang X, Huang Z, Zhang Y, Wang W, Ye Z, Liang P
Biosensors (Basel). 2024; 14(12).
PMID: 39727898
PMC: 11674896.
DOI: 10.3390/bios14120633.
Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine.
Azeez S, Hamad R, Hamad B, Shekha M, Bergsten P
Front Genome Ed. 2024; 6:1509924.
PMID: 39726634
PMC: 11669675.
DOI: 10.3389/fgeed.2024.1509924.